Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OncoMed Pharmaceuticals Inc (NASDAQ:OMED)

3.52
Delayed Data
As of May 25
 -0.14 / -3.83%
Today’s Change
3.25
Today|||52-Week Range
15.35
-54.35%
Year-to-Date
No recent news for OncoMed Pharmaceuticals Inc.

Today’s Trading

Previous close3.66
Today’s open3.70
Day’s range3.31 - 3.70
Volume1,727,859
Average volume (3 months)391,879
Market cap$132.4M
Dividend yield--
Data as of 05/25/2017

Growth & Valuation

Earnings growth (last year)-10.56%
Earnings growth (this year)+43.51%
Earnings growth (next 5 years)--
Revenue growth (last year)-2.88%
P/E ratioNM
Price/Sales10.07
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CRMECardiome Pharma Corp-0.01-0.24%
SBPHSpring Bank Pharmace...+0.30+2.20%
--China Health Group I...+0.00+2.96%
DRNADicerna Pharmaceutic...+0.00+0.00%
Data as of 05/26/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$25.2M
Annual profit (last year)-$103.1M
Net profit margin-409.90%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Paul J. Hastings
CFO, SVP-Corporate Development &
Finance
Sunil Patel
Corporate headquarters
Redwood City, California

Forecasts